MedPath

Lyrica

These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CVLYRICA (pregabalin) Oral Solution, CVInitial U.S. Approval: 2004

Approved
Approval ID

423acd42-650c-43fa-98f1-7d0fccceff6b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 12, 2011

Manufacturers
FDA

Lake Erie Medical Surgical & Supply DBA Quality Care Products LLC

DUNS: 831276758

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PREGABALIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code35356-053
Application NumberNDA021724
Product Classification
M
Marketing Category
C73594
G
Generic Name
PREGABALIN
Product Specifications
Route of AdministrationORAL
Effective DateJuly 18, 2011
FDA Product Classification

INGREDIENTS (12)

GELATINInactive
Code: 2G86QN327L
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
PREGABALINActive
Quantity: 25 mg in 1 1
Code: 55JG375S6M
Classification: ACTIB
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
POTASSIUM HYDROXIDEInactive
Code: WZH3C48M4T
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lyrica - FDA Drug Approval Details